Imprivata provides access management for healthcare and other mission-critical industries. Its portfolio covers single sign-on, multifactor authentication, mobile access, privileged access security, remote support, and user behaviour analytics, plus healthcare-specific functions such as patient privacy monitoring, drug diversion monitoring, medical device access management and electronic prescribing of controlled substances. Imprivata describes protection of customer data in both cloud and on-premises deployments, so organisations can run parts of it on their own infrastructure.
Imprivata, Inc. is headquartered in Waltham, Massachusetts, and is subject to US jurisdiction, including the CLOUD Act. Cloud hosting regions are not publicly named, and no EU data region is described. Its privacy policy appoints an EU representative in Germany, lists legal bases for processing and refers to safeguards for data transferred outside the EEA. The company reports ISO 27001 and ISO 27701 certification and a SOC 2 attestation. European healthcare organisations should confirm data residency and processor terms, and consider the dependency on a US identity provider for access to clinical systems.